Prescription drug · ANDA
Tizanidine hydrochloride NDC 85742-032
Tizanidine hydrochloride 4 mg/1 · Capsule · Oral · Kanchan Healthcare Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 85742-032-30 | 85742003230 | 150 CAPSULE in 1 BOTTLE (85742-032-30)Marketed from Dec 29, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tizanidine hydrochloride
- Generic name (nonproprietary)
- tizanidine hydrochloride
- Active ingredients
- Tizanidine hydrochloride — 4 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Kanchan Healthcare Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210021
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 85742-032_5813a435-c3d7-46df-a197-52f4ba5d8924SPL ID 5813a435-c3d7-46df-a197-52f4ba5d8924SPL set ID 22ea819a-2aaa-44e0-a350-258541b11220RxCUI 485484, 485485, 485486UNII B53E3NMY5C
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N485742003230followed by a unit qualifier and the quantityPackage 85742-0032-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tizanidine Hydrochloride Capsules are indicated for the treatment of spasticity in adults. Tizanidine Hydrochloride Capsules are a central alpha-2-adrenergic agonist indicated for the treatment of spasticity. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 210021
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | 71209-066 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-041 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | 71209-064 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Cadila Pharmaceuticals Limited | 71209-065 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 4 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-042 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Modavar Pharmaceuticals LLC | 72241-043 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 2 mg/1 | CapsuleOral | Kanchan Healthcare Inc | 85742-031 |
| Tizanidine hydrochloride | Tizanidine hydrochloride 6 mg/1 | CapsuleOral | Kanchan Healthcare Inc | 85742-033 |